Phase 1/2 trial of Evomela for autologous transplant in myeloma: schedule optimization and matched comparison with MEL200

Blood Advances · Elsevier

Аннотация

Publication date: 10 November 2026 Source: Blood Advances, Volume 10, Issue 21 Author(s): Qaiser Bashir, Peter F. Thall, Jitesh D. Kawedia, Xun Xu, Cristina G. Knape, Ruby Delgado, Yago Nieto, Neeraj Saini, Yosra M. Aljawai, Samer A. Srour, Jeremy L. Ramdial, Chitra Hosing, Uday R. Popat, Betul Oran, Partow Kebriaei, Sairah Ahmed, Oren Pasvolsky, Krina Patel, Sheeba Thomas, Mahmoud Gaballa

Читать у издателя →

Похожие статьи